iPSCs from people with MS can differentiate into oligodendrocytes in a homeostatic but not an inflammatory milieu.
Multiple sclerosis (MS) is an inflammatory and demyelinating disease of the central nervous system (CNS) that results in variable severities of neurodegeneration. The understanding of MS has been limited by the inaccessibility of the affected cells and the lengthy timeframe of disease development. H...
Main Authors: | Itzy E Morales Pantoja, Matthew D Smith, Labchan Rajbhandari, Linzhao Cheng, Yongxing Gao, Vasiliki Mahairaki, Arun Venkatesan, Peter A Calabresi, Kathryn C Fitzgerald, Katharine A Whartenby |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0233980 |
Similar Items
-
Conditional gene knockout and reconstitution in human iPSCs with an inducible Cas9 system
by: Mengyao Wu, et al.
Published: (2018-05-01) -
Integration-free erythroblast-derived human induced pluripotent stem cells (iPSCs) from an individual with Ataxia-Telangiectasia (A-T)
by: Niraj Bhatt, et al.
Published: (2016-09-01) -
iPSCs are safe!
by: Hualong Yan, et al.
Published: (2017-05-01) -
Enhanced axonal regeneration of ALS patient iPSC-derived motor neurons harboring SOD1A4V mutation
by: Katherine L. Marshall, et al.
Published: (2023-04-01) -
Nanog-Independent Reprogramming to iPSCs with Canonical Factors
by: Ava C. Carter, et al.
Published: (2014-02-01)